What is the purpose of this trial?
Using Clostridium perfringens enterotoxin (CPE), to target ovarian cancer cells based on their high levels of claudin-3 and -4 potentially represents a novel, highly effective therapeutic approach to treat metastatic and/or chemotherapy-resistant ovarian cancer.
Yale Cancer Center
Dates: 05/29/2008 - 04/04/2012
Last Updated: 07/31/2015
Study HIC#: 0804003671